24 phenotypes from 2 alleles in 4 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Ugt1tm1.1Afmu/Ugt1tm1.1Afmu B6.Cg-Ugt1tm1.1Afmu	decreased Purkinje cell number	J:216224
	increased circulating bilirubin level	J:216224
	jaundice	J:216224
	postnatal lethality, complete penetrance	J:216224
Ugt1tm1.1Afmu/Ugt1tm1.1Afmu FVB.Cg-Ugt1tm1.1Afmu	abnormal cerebellar Purkinje cell layer	J:216224
	abnormal cerebellum fissure morphology	J:216224
	abnormal cerebellum morphology	J:216224
	abnormal Purkinje cell dendrite morphology	J:216224
	decreased Purkinje cell number	J:216224
	dystonia	J:216224
	encephalopathy	J:216224
	impaired coordination	J:216224
	increased circulating bilirubin level	J:216224
	jaundice	J:216224
	lethargy	J:216224
	postnatal lethality, complete penetrance	J:216224
	seizures	J:216224
	thin external granule cell layer	J:216224
Ugt1tm1.1Afmu/Ugt1tm1.1Afmu involves: 129 * C57BL/6 * SJL	abnormal cerebellar granule layer morphology	J:182805
	abnormal cerebellar layer morphology	J:182805
	abnormal cerebellar Purkinje cell layer	J:182805
	abnormal cerebellum fissure morphology	J:182805
	abnormal cerebellum morphology	J:182805
	abnormal gallbladder morphology	J:182805
	abnormal limb posture	J:182805
	abnormal locomotor activation	J:182805
	abnormal motor capabilities/coordination/movement	J:182805
	abnormal Purkinje cell dendrite morphology	J:182805
	abnormal suckling behavior	J:182805
	ataxia	J:182805
	athetotic walking movements	J:182805
	decreased Purkinje cell number	J:182805
	dystonia	J:182805
	increased circulating bilirubin level	J:182805
	increased neuron apoptosis	J:182805
	jaundice	J:182805
	postnatal lethality, complete penetrance	J:182805
	thin external granule cell layer	J:182805
Ugt1tm1Rhtu/Ugt1tm1Rhtu involves: 129 * C57BL/6	increased circulating bilirubin level	J:133790
	jaundice	J:133790
	postnatal lethality, complete penetrance	J:133790